Literature DB >> 27239906

Efficient penetration of ceric ammonium nitrate oxidant-stabilized gamma-maghemite nanoparticles through the oval and round windows into the rat inner ear as demonstrated by MRI.

Jing Zou1,2, Stella Ostrovsky3, Liron L Israel3, Hao Feng2, Mikko I Kettunen4, Jean-Paul Moshe Lellouche3, Ilmari Pyykkö2.   

Abstract

We aimed to evaluate the magnetic resonance imaging (MRI) contrast effect and delivery efficiency through the middle ear into the inner ear using novel super-paramagnetic maghemite (γ-Fe2 O3 ) nanoparticles (NPs) generated using ceric ammonium nitrate (CAN)-mediated oxidation of Fe3 O4 NPs (CAN-γ-Fe2 O3 NPs). The CAN-γ-Fe2O3 NPs, having hydrodynamic diameters of 50-60 nm and potentials of +55.2 mV, displayed super-paramagnetic behavior characterized by a saturation magnetization Ms of 75.2 emu/g NPs. The r1 and r2* relaxivity (curve slopes) values were 0.0015 and 189 mmol-1  s-1 , respectively, indicating strong T2* relaxation maghemite-based NPs. The CAN-γ-Fe2 O3 NPs were stable in the 7.0 T magnetic field. At 3 h after the tympanic medial wall administration, the NPs had significantly located to the cochlea and vestibule. The signal started to recover at 6 h in the ipsilateral cochlea and by 2 d in the vestibule post-administration. There was no difference in the signal intensity between the left and right ears on the 14th d. Prussian blue staining for iron demonstrated NP distribution in the inner ear tissue. The novel CAN-γ-Fe2 O3 NPs are a strong MRI T2 contrast agent and penetrated the round and oval windows and have potential application in the molecular imaging of the inner ear.
© 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 105B: 1883-1891, 2017. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  biological barrier; functional maghemite nanoparticles; inner ear; magnetic resonance imaging; metal cation doping process for nanoparticle surface engineering

Mesh:

Substances:

Year:  2016        PMID: 27239906     DOI: 10.1002/jbm.b.33719

Source DB:  PubMed          Journal:  J Biomed Mater Res B Appl Biomater        ISSN: 1552-4973            Impact factor:   3.368


  8 in total

Review 1.  Innovative pharmaceutical approaches for the management of inner ear disorders.

Authors:  Umberto M Musazzi; Silvia Franzé; Francesco Cilurzo
Journal:  Drug Deliv Transl Res       Date:  2018-04       Impact factor: 4.617

Review 2.  Iron Oxide Nanoparticles in Regenerative Medicine and Tissue Engineering.

Authors:  Ralf P Friedrich; Iwona Cicha; Christoph Alexiou
Journal:  Nanomaterials (Basel)       Date:  2021-09-08       Impact factor: 5.719

Review 3.  Nanomaterials for Inner Ear Diseases: Challenges, Limitations and Opportunities.

Authors:  Liling Li; Jia Luo; Xuexin Lin; Jingqian Tan; Peng Li
Journal:  Materials (Basel)       Date:  2022-05-25       Impact factor: 3.748

Review 4.  Nanomedicine for Inner Ear Diseases: A Review of Recent In Vivo Studies.

Authors:  Dong-Kee Kim
Journal:  Biomed Res Int       Date:  2017-10-10       Impact factor: 3.411

Review 5.  Nanomaterial-mediated autophagy: coexisting hazard and health benefits in biomedicine.

Authors:  Xiaoli Feng; Yaqing Zhang; Chao Zhang; Xuan Lai; Yanli Zhang; Junrong Wu; Chen Hu; Longquan Shao
Journal:  Part Fibre Toxicol       Date:  2020-10-16       Impact factor: 9.400

Review 6.  Inner ear barriers to nanomedicine-augmented drug delivery and imaging.

Authors:  Jing Zou; Ilmari Pyykkö; Jari Hyttinen
Journal:  J Otol       Date:  2016-11-25

Review 7.  Developments in Bio-Inspired Nanomaterials for Therapeutic Delivery to Treat Hearing Loss.

Authors:  Christopher Rathnam; Sy-Tsong Dean Chueng; Yu-Lan Mary Ying; Ki-Bum Lee; Kelvin Kwan
Journal:  Front Cell Neurosci       Date:  2019-11-06       Impact factor: 5.505

8.  MRI detection of endolymphatic hydrops in Meniere's disease in 8 minutes using MIIRMR and a 20-channel coil after targeted gadolinium delivery.

Authors:  Jing Zou; Zhen Wang; Yukun Chen; Guoping Zhang; Luguang Chen; Jianping Lu
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2020-01-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.